Session Information

Free Paper

[FP-SA-48] Retinoblastoma, Lymphoma and Ocular Surface Tumors
Go back
print
Day
Apr 05 (Sat)
Time
15:30 - 17:00
Room
Room 15 - Tokyo International Forum 4F G407
Topic
Oncology
Chair/Coordinator
Chair)Luiz Teixeira、Chair)Bhavna Chawla

Duration 5min, Q&A 3min

FP-SA-48-1 / 

Oncology

Intravitreal Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds Provides Control with Minimal Complication

Fairooz Mandadavida

Intravitreal Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds Provides Control with Minimal Complication

Duration 5min, Q&A 3min

FP-SA-48-2 / 

Oncology

Outcome of Twenty Eyes with Recurrent or Refractory Retinoblastoma Using Selective Intra-Arterial and or Intravitreal Chemotherapy

Luiz Teixeira

Outcome of Twenty Eyes with Recurrent or Refractory Retinoblastoma Using Selective Intra-Arterial and or Intravitreal Chemotherapy

Duration 5min, Q&A 3min

FP-SA-48-3 / 

Oncology

Intraocular Fine Needle Aspiration Cytology for Retinoblastoma with Atypical Presentation : Is it Justified?

Bhavna Chawla

Intraocular Fine Needle Aspiration Cytology for Retinoblastoma with Atypical Presentation : Is it Justified?

Duration 5min, Q&A 3min

FP-SA-48-4 / 

Oncology

BRAF, NRAS and KIT Mutations in Primary Conjunctival Melanoma Correlated to Survival, Clinical, and Pathological Features

Ann-Cathrine Larsen

BRAF, NRAS and KIT Mutations in Primary Conjunctival Melanoma Correlated to Survival, Clinical, and Pathological Features

Duration 5min, Q&A 3min

FP-SA-48-5 / 

Oncology

ZEB-1 as a Prognostic Marker in Sebaceous Carcinoma of the Eyelid

Mansi Bhardwaj

ZEB-1 as a Prognostic Marker in Sebaceous Carcinoma of the Eyelid

Duration 5min, Q&A 3min

FP-SA-48-6 / 

Oncology

Sebaceous Carcinoma of the Eyelid: Outcomes and Prognostic Factors after Surgical Treatment

Takayoshi Kojima

Sebaceous Carcinoma of the Eyelid: Outcomes and Prognostic Factors after Surgical Treatment

Duration 5min, Q&A 3min

FP-SA-48-7 / 

Oncology

Association of Ocular Findings and Preventive Therapy with Onset of CNS Involvement in Patients with Primary Vitreoretinal Lymphoma

Noriyasu Hashida

Association of Ocular Findings and Preventive Therapy with Onset of CNS Involvement in Patients with Primary Vitreoretinal Lymphoma

Duration 5min, Q&A 3min

FP-SA-48-8 / 

Oncology

Usefulness of Fundus Autofluorescence Patterns in Evaluating Patients with Primary Vitreoretinal Lymphoma

Lisa Faia

Usefulness of Fundus Autofluorescence Patterns in Evaluating Patients with Primary Vitreoretinal Lymphoma

Duration 5min, Q&A 3min

FP-SA-48-9 / 

Oncology

The Efficiency of Using Interferon Alpha-2b in Surgical Treatment of Corneal and Conjunctival Malignant Tumors

Ruhangiz Balayeva

The Efficiency of Using Interferon Alpha-2b in Surgical Treatment of Corneal and Conjunctival Malignant Tumors

Duration 5min, Q&A 3min

FP-SA-48-10 / 

Oncology

Metastasis and Prognosis of Malignant Melanoma of the Conjunctiva

Yukiko Aihara

Metastasis and Prognosis of Malignant Melanoma of the Conjunctiva

Duration 5min, Q&A 3min

FP-SA-48-11 / 

Oncology

Solitary Eyelid Nodule Sebaceous Carcinoma: The Role of Map Biopsies When There Is No Evidence of Conjunctival Involvement

Erin Shriver

Solitary Eyelid Nodule Sebaceous Carcinoma: The Role of Map Biopsies When There Is No Evidence of Conjunctival Involvement

Go back